/ Industries

Pharmaceuticals & Biotechnology

The compute infrastructure that accelerates drug discovery and biotech research — precision, security and scale in one platform.

Computational methods are transforming the pace and cost of pharmaceutical and biotechnology research. Simulating protein-ligand interactions, analyzing genomic variants, or running large-scale molecular dynamics all demand compute capacity far beyond what standard server infrastructure can deliver.

The Role of HPC in Computational Drug Discovery

Traditional drug development takes an average of 10–15 years from compound discovery to clinical approval. Computational methods accelerate this process at two critical points:

  1. Early elimination: Filtering out biologically inactive compounds before wet-lab synthesis
  2. Mechanism understanding: Examining protein-ligand binding energy, conformational changes, and drug resistance at the atomic level

Both applications require substantial compute capacity.

Molecular Dynamics Simulations

Molecular dynamics (MD) is the most resource-intensive workload category in pharma and biotech HPC.

Common MD Software

SoftwareGPU SupportStrength
GROMACSExcellent (CUDA/OpenCL)Biomolecular simulations; free, open source
AMBERVery good (CUDA)Nucleic acids and proteins; PMEMD.cuda very fast
NAMDGood (CUDA)Large systems; multi-million atom (ribosome)
LAMMPSGood (CUDA/HIP)Materials science and polymer systems
OpenMMExcellent (CUDA)Python integration; ML force fields

Performance example: 100 ns GROMACS simulation (100,000 atom system):

  • 64 CPU cores: ~72 hours
  • Single NVIDIA H100: ~4 hours
  • 4× H100: ~1.2 hours

GPU acceleration delivers a decisive advantage for MD workloads.

Long-Timescale Simulations

Protein folding, allosteric transitions, and membrane permeation are slow processes requiring µs–ms scale simulation. These workloads use enhanced sampling methods (replica exchange, metadynamics) and require parallel execution at scale.

Genomics and Bioinformatics Pipelines

Next-generation sequencing (NGS) data analysis involves compute-intensive pipelines covering alignment, variant calling, and functional annotation.

Common Tools and HPC Requirements

  • BWA / BWA-MEM2: Reference alignment; linear scaling with CPU cores
  • GATK (Genome Analysis Toolkit): Variant calling standard; high I/O and RAM requirements
  • NVIDIA Parabricks: GPU-accelerated GATK pipeline — 50× faster than CPU GATK
  • STAR / HISAT2: RNA-seq alignment
  • DeepVariant: GPU-based variant calling (Google)

Typical genomic workload profile:

  • 30× WGS sample: 100–200 GB raw data
  • GATK Best Practices: 48–72 hours (CPU), 1–2 hours (Parabricks GPU)
  • High I/O intensity: Parallel filesystem required (BeeGFS/Lustre)

Protein Structure Prediction

Since AlphaFold 2’s release, computational protein structure prediction has entered a new era.

  • AlphaFold 2 / AlphaFold 3: NVIDIA GPU required; prediction in hours on A100/H100
  • RoseTTAFold: Similar GPU requirements
  • Rosetta: Protein design and protein-protein interaction; CPU-intensive, scales to hundreds of cores
  • AutoDock Vina / GNINA: GPU-accelerated molecular docking

Large-scale virtual screening (10,000+ ligands) optimally uses job array-based GPU cluster configurations.

Computational Chemistry

  • Gaussian / ORCA: Quantum chemistry; DFT and ab initio calculations; high memory requirement
  • Q-Chem: Fast DFT; linear-scaling methods for large molecules
  • VASP / Quantum ESPRESSO: Periodic systems, materials science; InfiniBand critical

Quantum chemistry workloads may require 512 GB–2 TB RAM per node; high-memory nodes are essential.

Data Security and Regulatory Compliance

Secure data management in pharmaceutical research is both legally and competitively critical.

Key Regulations

  • GDPR: Clinical data is personal data; processing and storage restrictions apply
  • GxP (GLP, GMP, GCP): Computations linked to clinical processes require data integrity and audit trails
  • 21 CFR Part 11: Electronic record and signature requirements for FDA-regulated submissions

On-premise infrastructure is the most reliable solution for meeting these requirements. Cloud alternatives require additional agreements and certifications.

Typical Pharma & Biotech HPC Configuration

Login Nodes (2×)
├── CPU Compute Nodes (16–32 units)
│   └── 2× AMD EPYC 9654, 512 GB DDR5
│       (Genomic alignment, Rosetta, ORCA)
├── GPU Compute Nodes (8–16 units)
│   └── 2× Intel Xeon + 4× NVIDIA H100 SXM5
│       (MD simulation, Parabricks, AlphaFold)
├── High-Memory Nodes (2–4 units)
│   └── 1–2 TB DDR5 (Gaussian, large NGS analysis)
└── Storage
    └── BeeGFS NVMe (scratch) + S3-compatible archive

Mevasis Pharma & Biotech HPC Services

Mevasis provides HPC infrastructure design, deployment, and management services tailored for research teams. GROMACS, AMBER, Parabricks, and AlphaFold installation and optimization are within our team’s core expertise. Contact us for HPC consulting or GPU rental options.


Frequently Asked Questions

Should I choose GPU or CPU for MD simulations? For modern MD software (GROMACS, AMBER), GPU is strongly recommended. An H100 GPU delivers 10–30× higher MD simulation throughput than an equivalent CPU cluster. CPUs remain relevant for large parallel MPI workloads that don’t scale well to GPU.

How much storage does genomic analysis require? 30× WGS generates ~100 GB raw FASTQ, ~200 GB intermediate files, and ~50 GB final BAM/VCF. Large cohort studies (100+ samples) require petabyte-scale storage planning.

How complex is AlphaFold installation? AlphaFold 2 installation requires attention due to database requirements (~2.2 TB). Mevasis provides turnkey AlphaFold deployment and update support.

Can clinical data be processed in the cloud? Under GDPR, processing personal health data with non-EU cloud providers carries legal risk. On-premise or locally-hosted managed infrastructure is preferred for regulated data.

← All Industries